Company Filing History:
Years Active: 2010
Title: Yvonne Håkansson: Innovator in Pharmaceutical Dosage Forms
Introduction
Yvonne Håkansson is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative oral dosage forms. With a total of 2 patents, her work focuses on improving treatments for conditions associated with gastric acid secretion.
Latest Patents
Håkansson's latest patents include a gastric acid secretion inhibiting composition. This oral pharmaceutical dosage form comprises pharmacologically effective amounts of an acid-susceptible proton pump inhibitor and an H2 receptor antagonist. The formulation includes at least one pharmacologically acceptable excipient that facilitates delayed and/or extended release of the proton pump inhibitor. The H2 receptor antagonist is designed to be rapidly released after administration. This innovative dosage form is suitable for treating conditions related to excessive gastric acid secretion, providing a combination of rapid onset and long-lasting effects. Additionally, her invention encompasses methods for manufacturing such dosage forms and for treating conditions associated with gastric acid secretion.
Career Highlights
Yvonne Håkansson is currently associated with Orexo AB, a company known for its focus on developing innovative pharmaceutical products. Her work at Orexo has been instrumental in advancing the field of pharmaceutical formulations.
Collaborations
Håkansson has collaborated with notable colleagues, including Anders Pettersson and Christer Nyström, contributing to the success of her projects and innovations.
Conclusion
Yvonne Håkansson's contributions to pharmaceutical innovations, particularly in gastric acid secretion treatments, highlight her role as a leading inventor in her field. Her work continues to impact the development of effective pharmaceutical solutions.